Continuous allocation score design for guaranteeing equity and reducing discards in kidney and liver transplantation
连续分配评分设计,保证肾移植和肝移植的公平性并减少丢弃
基本信息
- 批准号:10587447
- 负责人:
- 金额:$ 73.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-12-17 至 2027-11-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAgeAlgorithmsAmericanAntibodiesBiologicalBlack raceBloodBlood typing procedureCessation of lifeCharacteristicsChildhoodClinicalCollaborationsCommunitiesComplexDataDimensionsDisparityEnsureEquityEthicsEthnic OriginEvolutionFrustrationGenderGeographyGoalsHLA AntigensHospitalsIncidenceIschemiaKidneyKidney TransplantationLifeLiverLogisticsMatched GroupMethodologyMethodsNatural experimentOrganOrgan ProcurementsOrgan TransplantationOutcomeParticipantPoliciesPolicy MakerPopulationRaceRestRuralSolidStigmatizationSubgroupSystemTestingTimeTransplantationWait TimeWaiting ListsWeightbehavior changecombinatorialdesigndynamic systemethnic disparityflexibilitygeographic disparityimprovedinterestliver transplantationmathematical methodsmortalitymosaicorgan allocationorgan procurement transplantation networkracial disparitysimulationsocial health determinantssocioeconomic disparitysocioeconomicstooltransplant centers
项目摘要
PROJECT ABSTRACT
The benefits of kidney and liver transplantation should be available to all Americans, but geographic,
racial/ethnic, gender, and other disparities, plus a shortage of transplantable organs, have frustrated that
promise. Because organ allocation is a complex system in which every factor prioritized affects how other
factors are prioritized, policy changes that focus on one aspect (e.g. geographic disparity or panel reactive
antibody) in isolation often fail. Prior allocation changes have often resulted in unintended consequences. The
Organ Procurement and Transplantation Network (OPTN) has resolved to eliminate geographic boundaries in
favor of continuous allocation through implementation of a composite allocation score (CAS). However,
eliminating geographic boundaries impacts the rest of the system. To design a CAS for continuous allocation
that retains priorities of the current system without introducing unintended disparities requires simulation
optimization methods. These methods will maximize the survival benefit of transplantation while ensuring
equity by making transplant rates similar among populations that differ by race, gender, and social
determinants of health. To address the challenge of kidney and liver continuous allocation, we propose to
efficiently apply simulation and explore a vast number of alternative designs to choose a CAS that eliminates
geographic boundaries, as per the OPTN mandate, without inducing unintended new disparities. This system
will minimize waitlist deaths and maximize life-years gained from transplant, while assuring transplant rates for
relevant subgroups (e.g. by age, race, ABO blood type, urban/rural) comparable to the current system. We
then propose to improve on the CAS by making incidence rate ratios (the relative transplant rates between
races, genders, sensitization levels, etc.) closer to 1. Whether perfect equity along all these dimensions can be
achieved is an open question, but we will attempt to equalize access for every candidate. Finally, we will
explore ways the CAS might minimize discard of transplantable organs. We will use previously unavailable
timestamp data on organ offers to create a logistics and discard simulation that will predict how allocation
changes impact cold ischemia time and discards for the first time. Using this new tool, we will test prioritizing
offers to centers and candidates most likely to accept them, while maintaining equity of access. The score can
adapt flexibly as transplant center acceptance criteria change. Our findings will be immediately and directly
applicable to national conversations regarding kidney and liver allocation, using an approach that optimizes
outcomes and supports transparency, an ethical cornerstone in transplantation. Our methodology allows
stakeholders to enforce constraints on equity and outcomes in clinically detailed simulations of organ
allocation. In this era of continuous allocation, we can achieve more transplants–and assure they are more
equitably distributed–than ever before.
项目摘要
所有美国人都应该享受肾移植和肝移植的好处,但地理、
种族/民族、性别和其他差异,再加上可移植器官的短缺,都阻碍了这一点
承诺。因为器官分配是一个复杂的系统,其中每个优先考虑的因素都会影响其他因素
因素被优先考虑,政策变化集中在某一方面(例如地理差异或小组反应)
抗体)的分离常常会失败。先前的分配变更常常会导致意想不到的后果。这
器官获取和移植网络 (OPTN) 已决定消除器官获取和移植网络的地理界限
有利于通过实施综合分配评分(CAS)进行连续分配。然而,
消除地理边界会影响系统的其余部分。设计连续分配的 CAS
保留当前系统的优先级而不引入意外的差异需要模拟
优化方法。这些方法将最大限度地提高移植的生存效益,同时确保
通过使不同种族、性别和社会背景的人群之间的移植率相似来实现公平
健康的决定因素。为了应对肾脏和肝脏连续分配的挑战,我们建议
有效地应用仿真并探索大量替代设计,以选择可消除
根据 OPTN 的授权,地理边界不会引起意外的新差异。这个系统
将最大限度地减少候补死亡人数并最大限度地延长移植获得的生命年,同时确保移植率
与现行系统相当的相关亚组(例如,按年龄、种族、ABO 血型、城市/农村)。我们
然后建议通过制定发病率比率(不同时期之间的相对移植率)来改进 CAS
种族、性别、敏感度水平等)更接近 1。是否可以在所有这些维度上实现完美的公平
是否实现是一个悬而未决的问题,但我们将努力为每位候选人提供平等的机会。最后,我们将
探索 CAS 尽可能减少可移植器官丢弃的方法。我们将使用以前不可用的
器官上的时间戳数据可用于创建物流和丢弃模拟,以预测分配方式
变化影响冷缺血时间并首次丢弃。使用这个新工具,我们将测试优先级
向最有可能接受的中心和候选人提供录取通知书,同时保持平等的机会。分数可以
随着移植中心接受标准的变化灵活适应。我们的调查结果将立即直接
适用于有关肾脏和肝脏分配的全国对话,使用优化的方法
结果并支持透明度,这是移植的道德基石。我们的方法允许
利益相关者在器官的临床详细模拟中对公平性和结果施加限制
分配。在这个持续分配的时代,我们可以实现更多的移植,并确保它们更多
比以往任何时候都更公平地分配。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Allan B Massie其他文献
Allan B Massie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Allan B Massie', 18)}}的其他基金
Determinants of chronic kidney disease in African-American live kidney donors
非裔美国活体肾捐献者慢性肾病的决定因素
- 批准号:
9144380 - 财政年份:2015
- 资助金额:
$ 73.73万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 73.73万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 73.73万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 73.73万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 73.73万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 73.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 73.73万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 73.73万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 73.73万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 73.73万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 73.73万 - 项目类别:
Miscellaneous Programs